Proteomics

Dataset Information

0

Identification of proteome changes in apoptotic NSCLC cells


ABSTRACT: Here, we used an unbiased, functional target-discovery platform to identify immunogenic proteins from primary non-small cell lung cancer (NSCLC) cells that had been induced to apoptosis by cisplatin (CDDP) treatment in vitro, as compared with their live counterparts. Among the multitude of proteins identified, some of them were represented as fragmented proteins in apoptotic tumor cells, and acted as non-mutated neoantigens. Only the fragmented proteins elicited effective multi-specific T cell responses, upon a chemotherapy protocol including CDDP. Importantly, these responses further increased significantly upon anti-PD-1 therapy, and correlated with patients’ survival and decreased PD-1 expression.

INSTRUMENT(S): 4800 Proteomics Analyzer

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung

SUBMITTER: Alessio Grimaldi  

LAB HEAD: Vincenzo Barnaba

PROVIDER: PXD016997 | Pride | 2020-05-27

REPOSITORIES: Pride

altmetric image

Publications


Here, we developed an unbiased, functional target-discovery platform to identify immunogenic proteins from primary non-small cell lung cancer (NSCLC) cells that had been induced to apoptosis by cisplatin (CDDP) treatment in vitro, as compared with their live counterparts. Among the multitude of proteins identified, some of them were represented as fragmented proteins in apoptotic tumor cells, and acted as non-mutated neoantigens (NM-neoAgs). Indeed, only the fragmented proteins elicited effectiv  ...[more]

Similar Datasets

2017-07-10 | PXD006212 | Pride
2013-10-31 | E-MTAB-1353 | biostudies-arrayexpress
2015-10-05 | PXD002397 | Pride
2021-09-09 | PXD019580 | Pride
2023-03-10 | PXD021779 | Pride
2021-09-08 | PXD015697 | Pride
2016-03-31 | PXD002939 | Pride
2015-09-09 | PXD002075 | Pride
2022-02-15 | PXD019662 | Pride
2022-02-15 | PXD019666 | Pride